OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial
Product details
Registration number: SIN14243P
Classification: Prescription Only
Active ingredients: Oxaliplatin
Strength: 100.00 mg
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: VIATRIS PHARMACEUTICALS PTE. LTD.
ATC code: L01XA03
HSA approval date: 2 October 2012
Manufacturer(s): Mylan Laboratories Limited [OTL]
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14243P
Classification: Prescription Only
What active ingredients and strength are recorded for OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Oxaliplatin
Strength: 100.00 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: VIATRIS PHARMACEUTICALS PTE. LTD.
Which manufacturers and countries are listed for OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Mylan Laboratories Limited [OTL]
Manufacturing country/countries: INDIA
Where can I look up OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14243P or the exact product name OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial. The general register link does not preselect this product.
What are the source dates for this OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this OLIPLAT POWDER FOR SOLUTION FOR INJECTION 100 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14243P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)